CIK 0001427925
- Non-accelerated filer
- Smaller reporting company
TALPHERA, INC.
Sign in to watch- Ticker
- TLPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412193603
- Phone
- +1 650-216-3500
- Business address
- 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
- Former names
- ACELRX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-31 | Hamel Lawrence G Chief Development Officer | Grant or award | +6,876 | $1.49 | $10K | 24,371 |
| 2018-08-07 | EDWARDS MARK G Director | Purchase | +5,300 | $2.84 | $15K | 160,300 |
| 2018-08-07 | Angotti Vincent J. Chief Executive Officer | Purchase | +10,000 | $2.90 | $29K | 35,000 |
| 2018-08-06 | Palmer Pamela P Chief Medical Officer | Purchase | +37,000 | $2.75 | $102K | 456,134 |
| 2018-08-06 | ASADORIAN RAFFI Chief Financial Officer | Purchase | +5,000 | $2.75 | $14K | 32,000 |
| 2018-06-14 | ADAMS ADRIAN Director | Grant or award · Stock Options (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-14 | Afable Richard Director | Grant or award · Stock Options (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-14 | HOFFMAN C STEVEN Director | Grant or award · Stock Options (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-14 | EDWARDS MARK G Director | Grant or award · Stock Options (Right to Buy) | +15,000 | 15,000 |
Page 17 of 17 · 329 trades